VF
JSPRW icon

Virtu Financial’s Japer Therapeutics Warrants JSPRW Stock Holding History

Virtu Financial’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,114
Closed – – 1983
2025
Q4 		$0 Buy
+10,114
New +$1.14K ﹤0.01% 1946

Other funds holding JSPRW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtu Financial's JSPRW Position: Q1 2026 in Review

Virtu Financial sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2026, closing a stake of 10,114 shares.

Virtu Financial first reported a position in JSPRW in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 7 funds tracked by Wall St. Rank hold JSPRW as of Q1 2026.

  • Virtu Financial reported no remaining Japer Therapeutics Warrants position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,114 Japer Therapeutics Warrants shares in Q1 2026.
  • Virtu Financial first reported a position in Japer Therapeutics Warrants in Q4 2025 and held it in 1 quarter.
  • Virtu Financial's Japer Therapeutics Warrants position peaked at $0 in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.